2[2]Cusi K, Consoli A, DeFronzo R. Metabolic effects of metformin on glucose and lactate metabolism in NIDDM. J Clin Endo Metab 1996;81:4059.
3[3]Cusi K, DeFronzo R. Metformin: a review of its metabolic effects. Diabetes Reviews 1998; 6: 89.
4[4]UK Prospective Diabetes Study (UKPDS) Group. Intensitve blood glucose control with metformin on complications in overweight patients with type 2 diabetes. Lancet 1998; 352:854.
5[5]Drager E. Clinical Profile of glimepiride. Dia Res Clin Pract 1995;28(Suppl) :S139.
6[6]Scheen AJ. Durg Treatment of non - insulin - dependent diabetes mellitus in the 1990s. Achievements and future developments. Drugs 1997;54:355.
7[1]Ohkubo Y, Kishikawa H,Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective-year study. Diabetes Res Clin Pract, 1995,28(3): 103
8[2]UK prospective diabetes study group. Intensive blood glucose con
9[3]trol with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes: UKPDS 33. Lancet, 1998,352(7) :837
10[6]Owens DR. Repaglinide-prandial glucose regulator: a new class of oral antidiabetic drugs. Diabet Med, 1998,15 ( 4 ): 28
1Yki-Jarvinen H. Combination therapies with insulin in type 2 diabetes[J]. Diabetes Care,2001,24(4) :758-767.
2Drouin P, Blickle JF, Charbonnel B, et al. Diagnosis and classification of diabetes mellitus: the new criteria[J]. Diabetes Metab, 1999,25(1) :72-83.
3Ceriello A, Cavarape A, Martinelli L, et al. The post-prandial state in type 2 diabetes and endothelial dysfunction: effects of insulin aspart[J]. Diabet Med,2004,21(3) :171-175.
